Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzyl lysine eye drops versus placebo for early senile cataract
ChiCTR2000031790Phase 4Recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bendazac in senile cataract (ARC) (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoints: Turbidity of crystalline lens under slit-lamp, Best corrected visual acuity and 1 more. Started Apr 2020; status: recruiting.
02
Drugs
bendazac
03
Conditions
senile cataract (ARC)
Beyond the preview
Go deeper on ChiCTR2000031790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031790.